Related Experiment Video
Updated: Jun 8, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Automatic Detection of Stress States in Type 1 Diabetes Subjects in Ambulatory Conditions
Daniel A Finan1, Howard Zisser, Lois Jovanovič
1Department of Chemical Engineering, University of California, Santa Barbara, CA 93106-5080.
Abstract:
Two levels of control are crucial to the robustness of an artificial β-cell, a medical device that would automatically regulate blood glucose levels in patients with type 1 diabetes. A low-level component would attempt to regulate blood glucose continuously, while a supervisory-level, or monitoring, component would detect underlying changes in the subject's glucose-insulin dynamics and take corrective actions accordingly. These underlying changes, or "faults," can include changes in insulin sensitivity, sensor problems, and insulin delivery problems, to name a few. A multivariate statistical monitoring technique, principal component analysis (PCA), has been applied to both simulated and experimental type 1 diabetes data. The objective of this study was to determine if PCA could be used to distinguish between normal patient data, and data for abnormal conditions that included a variety of "faults." The PCA results showed a high degree of accuracy; for data from nine type 1 diabetes subjects in ambulatory conditions, 33 of 37 total test days (89%), including fault days and normal days, were classified correctly. Thus, the proposed monitoring technique shows considerable promise for incorporation into an artificial β-cell.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
